ShareValue scores for DXRX.LSE: Valuation 38, Quality 55, Growth 54, Health 51.

DXRX.LSE
LSE

Diaceutics PLC

£1.50(+3.10%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-5% to 10%
Valuation
38
Overvalued
Price vs Value
Quality
55
Moderate
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
39
Bearish
Price Trend

Company Details

About

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026